U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT06801795) titled 'Aviclear for Hidradenitis Suppurativa (HS)' on Jan. 24.
Brief Summary: The objective is to evaluate the safety and efficacy of the Cutera 1726 nm laser system (also referred to as AviClear) for the treatment of HS.
Study Start Date: March 01
Study Type: INTERVENTIONAL
Condition:
Hidradenitis Suppurativa
Intervention:
DEVICE: AviClear
Participants will receive as many as 4 treatments, each treatment lasts approximately 10 minutes, with intervals of up to 5 weeks apart. The treatments will be conducted in person. Participants will be followed at approximately week 5 post-treatment completion (via phone) at 12 weeks and 24 weeks...